376 related articles for article (PubMed ID: 38365716)
41. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
[TBL] [Abstract][Full Text] [Related]
42. Bioplatforms in liquid biopsy: advances in the techniques for isolation, characterization and clinical applications.
Shah UJ; Alsulimani A; Ahmad F; Mathkor DM; Alsaieedi A; Harakeh S; Nasiruddin M; Haque S
Biotechnol Genet Eng Rev; 2022 Oct; 38(2):339-383. PubMed ID: 35968863
[TBL] [Abstract][Full Text] [Related]
43. Circulating Cell-Free DNA Yield and Circulating-Tumor DNA Quantity from Liquid Biopsies of 12 139 Cancer Patients.
Huang RSP; Xiao J; Pavlick DC; Guo C; Yang L; Jin DX; Fendler B; Severson E; Killian JK; Hiemenz M; Duncan D; Lin DI; Dennis L; Aiyer A; Gjoerup O; Oxnard G; Venstrom J; Elvin J; Ramkissoon SH; Ross JS
Clin Chem; 2021 Nov; 67(11):1554-1566. PubMed ID: 34626187
[TBL] [Abstract][Full Text] [Related]
44. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes.
El-Mallawany NK; Curry CV; Allen CE
Br J Haematol; 2022 Jan; 196(1):31-44. PubMed ID: 34169507
[TBL] [Abstract][Full Text] [Related]
45. Liquid biopsy = Individualized cancer management: Diagnosis, monitoring treatment and checking recurrence and metastasis.
Mali SB; Dahivelkar S
Oral Oncol; 2021 Dec; 123():105588. PubMed ID: 34744021
[TBL] [Abstract][Full Text] [Related]
46. Liquid Biopsy in Oral Cancer.
Lousada-Fernandez F; Rapado-Gonzalez O; Lopez-Cedrun JL; Lopez-Lopez R; Muinelo-Romay L; Suarez-Cunqueiro MM
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890622
[TBL] [Abstract][Full Text] [Related]
47. Liquid biopsy in non-small cell lung cancer: a key role in the future of personalized medicine?
Pi C; Zhang MF; Peng XX; Zhang YC; Xu CR; Zhou Q
Expert Rev Mol Diagn; 2017 Dec; 17(12):1089-1096. PubMed ID: 29057681
[TBL] [Abstract][Full Text] [Related]
48. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
49. DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection.
Markou Α; Londra D; Tserpeli V; Kollias Ι; Tsaroucha E; Vamvakaris I; Potaris K; Pateras I; Kotsakis Α; Georgoulias V; Lianidou Ε
Clin Epigenetics; 2022 May; 14(1):61. PubMed ID: 35538556
[TBL] [Abstract][Full Text] [Related]
50. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.
Alix-Panabières C; Pantel K
Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689
[TBL] [Abstract][Full Text] [Related]
51. Systemic EBV-positive T-cell lymphoma of childhood mimicking anaplastic large cell lymphoma.
Chen Z; Liu W; Zhao S
Br J Haematol; 2019 Jun; 185(6):1016. PubMed ID: 31172518
[No Abstract] [Full Text] [Related]
52. The potential of liquid biopsies in gastrointestinal cancer.
Wu C; Zhang J; Li H; Xu W; Zhang X
Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
[TBL] [Abstract][Full Text] [Related]
53. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.
Bracht JWP; Mayo-de-Las-Casas C; Berenguer J; Karachaliou N; Rosell R
Curr Oncol Rep; 2018 Jul; 20(9):70. PubMed ID: 30030656
[TBL] [Abstract][Full Text] [Related]
54. When Tissue Is the Issue: Expanding Cell-Free DNA "Liquid Biopsies" to Supernatants and Nonplasma Biofluids.
Paulson V; Konnick EQ; Lockwood CH
Clin Lab Med; 2022 Sep; 42(3):485-496. PubMed ID: 36150825
[TBL] [Abstract][Full Text] [Related]
55. Circulating tumor DNA as liquid biopsy in lung cancer: Biological characteristics and clinical integration.
Li C; Shao J; Li P; Feng J; Li J; Wang C
Cancer Lett; 2023 Nov; 577():216365. PubMed ID: 37634743
[TBL] [Abstract][Full Text] [Related]
56. The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH.
Liang JH; Lu L; Zhu HY; Li W; Fan L; Li JY; Xu W
Cancer Res Treat; 2019 Jan; 51(1):150-157. PubMed ID: 29621877
[TBL] [Abstract][Full Text] [Related]
57. Methods for the Detection of Circulating Biomarkers in Cancer Patients.
Mondelo-Macía P; Rodríguez-Ces AM; Suárez-Cunqueiro MM; Romay LM
Adv Exp Med Biol; 2022; 1379():525-552. PubMed ID: 35761006
[TBL] [Abstract][Full Text] [Related]
58. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology.
Ray SK; Mukherjee S
Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128
[TBL] [Abstract][Full Text] [Related]
59. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.
Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R
Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301
[TBL] [Abstract][Full Text] [Related]
60. Liquid Biopsy: Approaches to Dynamic Genotyping in Cancer.
von Bubnoff N
Oncol Res Treat; 2017; 40(7-8):409-416. PubMed ID: 28693026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
